Advertisement
Loading...

cbdMD, Inc.

YCBD•AMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.77
$-0.04(-5.32%)
U.S. Market opens in 28h 26m

cbdMD, Inc. (YCBD) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.9M
P/E Ratio-0.01
EPS (TTM)$0.60
ROE-0.38%
Fundamental Analysis

AI Price Forecasts

1 Month$0.75
3 Months$1.26
1 Year Target$0.00

YCBD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of cbdMD, Inc. (YCBD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 7.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.59%
5-Day Change
-12.94%
1-Month Change
-3.88%
3-Month Change
6.79%
6-Month Change
16.64%
Year-to-Date (YTD) Change
-44.53%
1-Year Change
-24.36%
3-Year Change
-95.41%
5-Year Change
-99.93%
All-Time (Max) Change
-99.96%

Contact Information

https://www.cbdmd.com
704 445 3060
8845 Red Oak Boulevard, Charlotte, NC, 28217

Company Facts

42 Employees
IPO DateNov 17, 2017
CountryUS
Actively Trading

Frequently Asked Questions